Emergent BioSolutions Inc. — Director's Dealing 2020

Mar 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2020-03-04

Reporting Person: SULLIVAN LOUIS W (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-04	Common Stock	M	7893	$13	Acquired	68359	Direct
2020-03-04	Common Stock	S	7893	$58.9582	Disposed	60466	Direct
2020-03-04	Common Stock	M	7893	$14.71	Acquired	68359	Direct
2020-03-04	Common Stock	S	7893	$58.9582	Disposed	60466	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-03-04	Employee Stock Options (Right to Buy)	$14.71	M	7893	Disposed	2020-05-20	Common Stock (7893.0)	Direct
2020-03-04	Employee Stock Options (Right to Buy)	$13.0	M	7893	Disposed	2020-05-23	Common Stock (7893.0)	Direct

Footnotes

F1: The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices at prices ranging from $58.75 to $59.14.

F2: Consists of stock options granted under the Company's Stock Incentive Plan, as amended and restated.

F3: The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.